Dr. Korc comes to IU from Dartmouth Medical School where he held the Joseph M. Huber Professor of Medicine and a professor of pharmacology and toxicology at The Dartmouth Institute for Health Policy and Clinical Practice. Before coming to IU, in 2003 he served as chair of the Dartmouth Hitchcock Medical Center Department of Medicine and as a member of the Section of Endocrinology. From 2008 to 2010, he was the associate dean for clinical and translational research at Dartmouth. Dr. Korc received his medical degree in 1974 from Albany Medical College in Albany, NY. He completed internal medicine training at Albany Medical Center Hospital in 1977 and an endocrinology fellowship in 1979 at the University of California, San Francisco. Dr. Korc's research has been continuously funded by the National Institutes of Health (NIH) since 1981. His focus is on aberrant growth-factor signaling in pancreatic cancer and genetic mouse models of pancreatic cancer, with the goal of designing novel therapeutic strategies. He has published more than 250 peer-reviewed manuscripts, and he is internationally recognized for his seminal contributions to the understanding of the role of the EGF receptor and transforming growth factor-beta in pancreatic cancer, work recently recognized by an NIH MERIT award. The NIH presents the highly-selective MERIT Awards to researchers who demonstrate superior competence and outstanding productivity in research endeavors. He is the first Myles Brand Professor.